LEADER 03353nam  2200685Ia 450 
001 9910452595303321
005 20200520144314.0
010   $a0-19-174010-1
010   $a0-19-960722-2
010   $a1-283-57980-4
010   $a9786613892256
010   $a0-19-157548-8
035   $a(CKB)2550000000105390
035   $a(EBL)975577
035   $a(OCoLC)801363641
035   $a(SSID)ssj0000627883
035   $a(PQKBManifestationID)12284434
035   $a(PQKBTitleCode)TC0000627883
035   $a(PQKBWorkID)10702160
035   $a(PQKB)10132613
035   $a(MiAaPQ)EBC975577
035   $a(StDuBDS)EDZ0000091479
035   $a(Au-PeEL)EBL975577
035   $a(CaPaEBR)ebr10581379
035   $a(CaONFJC)MIL389225
035   $a(EXLCZ)992550000000105390
100   $a20100707d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aCardioprotection$b[electronic resource] /$fedited by Derek J. Hausenloy, Derek Yellon
210   $aOxford ;$aNew York $cOxford University Press$dc2009
215   $a1 online resource (138 p.)
225 1 $aOxford cardiology library
300   $aDescription based upon print version of record.
311   $a0-19-954476-X 
320   $aIncludes bibliographical references and index.
327   $aContents; Foreword; Symbols and abbreviations; Contributors; 1 An Introduction to Cardioprotection; 2 Primary Prevention of Coronary Heart Disease; 3 Percutaneous Coronary Intervention and Thrombolysis in AMI and other ACS; 4 Anti-Platelet and Anti-Thrombotic Therapy Post-AMI; 5 Coronary No-Reflow and Microvascular Obstruction; 6 Optimal Medical Therapy Post-AMI; 7 Cardioprotection During Cardiac Surgery; 8 Endogenous Mechanisms of Cardioprotection; 9 Adjunctive Reperfusion Therapy Post-AMI; 10 Stem Cell Therapy Post-AMI; 11 Novel Cardioprotective Strategies; Index; A; B; C; D; E; F; G; H; I
327   $aJK; L; M; N; O; P; Q; R; S; T; U; V; W
330   $aCoronary heart disease (CHD) is the leading cause of death worldwide with 3.8 million men and 3.4 million women dying each year. Cardioprotection refers to the prevention of CHD and the clinical improvement in patients suffering from cardiovascular problems. This book focuses on the role of cardioprotection in surgery and the use of pharmacological therapies such as ACE-inhibitors, statins and beta-blockers in order to reduce the myocardial injury sustained by the patient and thesignificant risk of morbidity and mortality. It includes new cardioprotective strategies aimed at improving the clin
410  0$aOxford cardiology library.
606   $aCoronary heart disease$xTreatment$vHandbooks, manuals, etc
606   $aCoronary artery bypass$vHandbooks, manuals, etc
606   $aCardiovascular system$xDiseases$xTreatment$vHandbooks, manuals, etc
608   $aElectronic books.
615  0$aCoronary heart disease$xTreatment
615  0$aCoronary artery bypass
615  0$aCardiovascular system$xDiseases$xTreatment
676   $a616.1/23
701   $aHausenloy$b Derek J$0901021
701   $aYellon$b Derek M$0901022
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910452595303321
996   $aCardioprotection$92013998
997   $aUNINA